Brief Report: Stepdown Single Agent Antibiotic Therapy for the Management of the High Risk Neutropenic Adult with Hematologic Malignancies

Leukemia and Lymphoma

Volumn 23, Issue 42006, 1996, Pages 159-163

  Horowitz, Harold W ^a   Holmgren, Diane ^a   Seiter, Karen ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

antibiotics; hematologic; malignancies; neutropenia; sequential; therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTILEUKEMIC AGENT; CIPROFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COST; FEVER; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; FLUCONAZOLE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEUTROPENIA; RISK FACTORS;

EID: 0029842288     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199609054816     Document Type: Article

References (16)

1. Hughes W. T., Armstrong D., Bodey G. P., et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 1990; 161: 381–396
2. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia. Ann. Intern. Med. 1966; 64: 328–340
3. Pizzo P. A., Robichaud K. J., Gill F. A., et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am. J. Med 1979; 67: 194–200
4. Talcott J. A., Finberg R., Mayer R. J., Goldman L. The medical course of cancer patients with fever and neutropenia. Arch. Intern. Med. 1988; 148: 2561–2568
5. Khan F. A., Basir R. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 1989; 96: 528–537
6. Janknegt R., Van Der Meer J. W. M. Antibiotic practice: sequential therapy with intravenous and oral cephalosporins. J. Antimicrob. Chemother. 1994; 33: 169–177
7. Gelfand M. S., Simmons B. P., Craft R. B., Grogan J. T. Brief report: clinical study of intravenous and oral ciprofloxacin incomplicated bacterial infections. Am. J. Med. 1989; 87 (suppl 5A) 35S – 37S
8. Talcott J. A., Whalen A., Clark J., Rieker P. P., Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J. Clin. Oncol. 1994; 12: 107–114
9. Malik I. A., Kahn W. A., Karim M., Aziz Z., Khan M. A. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am. J. Med. 1995; 98: 224–231
10. Gardembas-Pain M., Desablens B., Sensebe L., Lamy Th., Ghandour Ch., Boasson M. Home treatment of febrile neutropenia: an empirical oral antibiotic regimen. Annals. Onc. 1991; 2: 485–487
11. Malik I. A., Khan W. A., Aziz Z., Karim M. Self-administered antibiotic therapy for chemotherapy-induced low-risk febrileneutropenia in patients with nonhematologic neoplasms. Clin. Infect. Dis. 1994; 19: 522–527
12. Rubenstein E. B., Rolston K., Benjamin R. S., et al. Out-patient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640–3646
13. Malik I. A., Abbas Z., Karim M. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 1992; 339: 1092–1096
14. Bash R. O., Katz J. A., Cash J. V., Buchanan G. R. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 1994; 74: 189–196
15. Kaplan A. H., Weber D. J., Davis L., Israel F., Wells R. J. Short courses of antibiotics in selected febrile neutropenic patients. Am. J. Med. Sci. 1991; 302: 353–354
16. Cornelissen J. J., Rozenberg-Arska M., Dekker A. W. Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin. Clin. Infect. Dis. 1995; 21: 1300–1302